PFE · News · 20260808N
Litigation and Legal Risk
PFIZER INC · 2026-08-08 · Importance 28 · Surprise 42 · In source text
Pfizer agreed to pay $44 million to settle a class-action lawsuit concerning Chantix and alleged undisclosed nitrosamine contamination. The settlement covers U.S. individuals and third-party payors who purchased Chantix between September 29, 2015, and September 17, 2021. Claimants must submit applications by September 14, 2026, and distributions will be allocated proportionally to purchase amounts. The digest does not state whether Pfizer recorded a related charge in the second quarter.
Key facts
- Pfizer will pay $44 million to settle a class-action lawsuit concerning Chantix covering U.S. individuals and third-party payors who purchased Chantix between September 29, 2015, and September 17, 2021. source
- Claimants in the Chantix settlement must file by September 14, 2026 to receive compensation. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | negative | committed | — | Pfizer will pay $44 million to settle a class-action lawsuit concerning Chantix covering U.S. individuals and third-party payors who… |
| cash | negative | committed | — | Pfizer will pay $44 million to settle a class-action lawsuit concerning Chantix covering U.S. individuals and third-party payors who… |